ICON to Acquire Aptiv Solutions - Applied Clinical Trials

ADVERTISEMENT

See our 2013 Buyers Guide Digital Edition.
ICON to Acquire Aptiv Solutions

Source: Applied Clinical Trials

ICON announced its intention to acquire Aptiv Solutions, a Reston, Va.-based services organization with operations in 16 countries. According to a press release, ICON views Aptiv's strengths in the design and execution of adaptive clinical trials through its ADDPLAN software a strength for its clients. Aptiv also owns a full-service, oncology-focused CRO in Japan, which will be combined with ICON's current operations in Tokyo and Osaka.

Read the full release here.

ADVERTISEMENT

blog comments powered by Disqus

ADVERTISEMENT

UPCOMING CONFERENCES

8th Annual Forum on Transparency and Aggregate Spend 2014
Washington, DC
August 18-20, 2014

eSource Data in Clinical Investigations
Philadelphia, PA
August 20-21, 2014

Pharmacovigilance 2014
Philadelphia, PA
September 10-11, 2014

Collaborative Research Summit
Philadelphia, PA
October 15-16, 2014

See All Conferences >>

Survey
As it creates a plan to implement the US biosimilar pathway, should FDA:
Borrow heavily from EMA's pathway program?
Borrow lightly from EMA's pathway program?
Create entirely its own pathway program?
Borrow heavily from EMA's pathway program?
87%
Borrow lightly from EMA's pathway program?
6%
Create entirely its own pathway program?
8%
View Results
Untitled Document
Source: Applied Clinical Trials,
Click here